Lundbeck
HLUN-B.CO
#2717
Rank
โ‚น557.21 B
Marketcap
โ‚น561.62
Share price
-0.15%
Change (1 day)
25.31%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): โ‚น66.53 Billion

According to Lundbeck's latest financial reports the company's current earnings are โ‚น3.80 Billion. , an increase over its 2024 earnings that were of โ‚น52.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น72.31 B38.47%
2024 โ‚น52.22 B25.74%
2023 โ‚น41.53 B21.77%
2022 โ‚น34.10 B31.57%
2021 โ‚น25.92 B-4.61%
2020 โ‚น27.17 B-45.06%
2019 โ‚น49.47 B-34.04%
2018 โ‚น75.00 B12.83%
2017 โ‚น66.47 B93.99%
2016 โ‚น34.26 B-137.28%
2015 -โ‚น91.92 Billion-1246.24%
2014 โ‚น8.01 B-72.36%
2013 โ‚น29.01 B4.38%
2012 โ‚น27.79 B-55.18%
2011 โ‚น62.01 B5.65%
2010 โ‚น58.69 B-5.9%
2009 โ‚น62.38 B